# US 2012/0252096 A1 · Mutant proteinase with reduced self-cleavage activity and method of purification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252096 A1
- Document ID: US20120252096A1
- Status: Published application
- Kind: A1
- Application number: 13/482,535
- Filed: 2012-05-29
- Published: 2012-10-04
- Earliest claimed: 2000-06-15
- Assignees: Yale University
- Inventors: Jennifer A. DOUDNA; Louise J. Lucast; Robert T. Batey
- Web page: https://patentgrep.com/patent/US20120252096A1

## CPC

- C12N 9/506: {derived from RNA viruses}
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12P 21/06: produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00)
- C07K 2319/00: Fusion polypeptide
- C07K 2319/21: containing a His-tag
- C12Y 304/22044: Nuclear-inclusion-a endopeptidase (3.4.22.44)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES

## Abstract

The present invention provides a mutant 27 kDa NIa proteinase having reduced self-cleavage activity relative to the self-cleavage activity of its wild-type proteinase. The mutant has the same substrate cleavage activity as the wild-type proteinase but is more stable than the wild-type proteinase. The present invention also provides a method of obtaining large quantities of active 27 kDa NIa proteinase for use as a tool for purification of other proteins.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

An isolated active mutant proteinase that recognizes and cleaves a substrate cleavage site recited in SEQ ID NO: 1, wherein the isolated active mutant proteinase has reduced self-cleavage activity relative to self-cleavage activity of a corresponding wild-type proteinase, and wherein the isolated active mutant proteinase has a single amino acid change in its internal self-cleavage site at a residue corresponding to Ser 219 of a wild-type TEV proteinase.

### Claim 22 (depends on 21)

The isolated active mutant proteinase of claim 21, wherein the mutant proteinase has a same or substantially same substrate cleavage activity as the corresponding wild-type proteinase.

### Claim 23 (depends on 21)

The isolated active mutant proteinase of claim 21, wherein the mutant proteinase has at least about 90% sequence identity to a wild-type 27 kDa NIa proteinase.

### Claim 24 (depends on 21)

The isolated active mutant proteinase of claim 21, wherein the mutant proteinase has at least about 95% sequence identity to a wild-type 27 kDa NIa proteinase.

### Claim 25 (depends on 21)

A fusion protein comprising the mutant proteinase of claim 21 fused to a heterologous polypeptide.

### Claim 26 (depends on 26)

The fusion protein of claim 26, wherein the heterologous polypeptide consists of six histidines.

### Claim 27

An isolated active mutant proteinase comprising an amino acid sequence in which a residue corresponding to Ser 219 of a wild-type TEV proteinase is replaced with another residue, wherein the isolated active mutant proteinase has reduced self-cleavage activity relative to self-cleavage activity of a corresponding wild-type proteinase, and wherein the isolated active mutant proteinase recognizes and cleaves a substrate cleavage site recited in SEQ ID NO: 1.
